Page 264 - Drug Class Review

Page 162 of 205
Drug Effectiveness Review Project

Study design: Observational cohort pharmacovigilance study (prescription event monitoring)

To report the incidence of adverse events associated with DON

Patients who received DON within the first few months of its launch

Alzheimer Drugs Authors: Dunn et al. 84 Year: 2000 Country: UK Drug and Safety Research Unit Setting: Questionnaires to general practitioners in the UK Sample size: 3,356 questionnaires sent; 1,762 returned donepezil N/A N/A 1,762 NR NR

Final Report Update 1 Adverse Events STUDY: FUNDING: RESEARCH OBJECTIVE: DESIGN: INTERVENTION: Dose: Duration: Sample size: INCLUSION: EXCLUSION: OTHER MEDICATIONS/ INTERVENTIONS ALLOWED: Alzheimer's Drugs